08/14/2024
7:29 AM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:21 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
8:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:26 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:27 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/19/2024
4:30 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:12 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:07 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:58 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:46 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:23 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:51 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
6:34 AM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
5:08 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:35 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:54 PM | ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:58 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:59 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:02 PM | ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:03 PM | ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:45 PM | ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:14 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:21 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:05 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
3:59 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
6:47 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Biden's Successor: The Radical Threat to YOUR Savings! (Ad) Kamala Harris isn't just playing politics; she's a serious threat to your financial security.
Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL. >> Get Your FREE Wealth Protection Guide << |
05/13/2024
4:25 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:09 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:26 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:43 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:33 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:19 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
8:33 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:12 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:13 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
8:53 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024
5:59 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:17 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:09 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:30 AM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
03/13/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:48 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:58 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
5:39 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:43 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:25 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
8:42 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:16 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:58 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
4:31 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:24 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:18 PM | ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:09 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:12 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:18 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:55 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:22 AM | ANI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:58 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:47 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:53 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:34 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:26 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
02/13/2024
7:05 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
5:06 AM | ANI Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024
7:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
5:14 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
4:32 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:52 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:30 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
5:20 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:06 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free ANIP Stock Alerts